These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9621405)

  • 21. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
    Kopp AF; Laniado M; Dammann F; Stern W; Grönewäller E; Balzer T; Schimpfky C; Claussen CD
    Radiology; 1997 Sep; 204(3):749-56. PubMed ID: 9280254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
    Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
    Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
    Kuwatsuru R; Brasch RC; Mühler A; Mathur A; Vexler VS; Rosenau W; Mintorovitch J; Berthezene Y; Cohen F; Shames DM
    Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis.
    Briley-Saebo KC; Mani V; Hyafil F; Cornily JC; Fayad ZA
    Magn Reson Med; 2008 Apr; 59(4):721-30. PubMed ID: 18383304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
    Pleger B; Beyer HK; Laufer U
    Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
    [No Abstract]   [Full Text] [Related]  

  • 30. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
    Chachuat A; Bonnemain B
    Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiation induced liver injury detected by particulate reticuloendothelial contrast agent.
    Padhani AR; Husband JE; Gueret Wardle D
    Br J Radiol; 1998 Oct; 71(850):1089-92. PubMed ID: 10211072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
    De Gaspari A; De Cobelli F; Del Maschio A
    Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
    Balzer T; Carter EC; Shamsi K; Niendorf HP
    Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619
    [No Abstract]   [Full Text] [Related]  

  • 34. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S
    J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver MR imaging with iron oxides: toward consensus and clinical practice.
    Weissleder R
    Radiology; 1994 Dec; 193(3):593-5. PubMed ID: 7972790
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiomyolipoma of the liver: ferumoxides-enhanced MR imaging.
    Ketelslegers E; Van Beers BE; Sempoux C
    Eur Radiol; 2000; 10(9):1401-3. PubMed ID: 10997427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences.
    Schwartz LH; Seltzer SE; Adams DF; Tempany CM; Piwnica-Worms DR; Silverman SG; Herman L; Herman LT; Hooshmand R
    Invest Radiol; 1994 Jun; 29 Suppl 2():S21-3. PubMed ID: 7928234
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
    Bellin MF; Zaim S; Auberton E; Sarfati G; Duron JJ; Khayat D; Grellet J
    Radiology; 1994 Dec; 193(3):657-63. PubMed ID: 7972804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferumoxides and Tc-99m sulfur colloid: comparison of the tumor-to-liver uptake in focal nodular hyperplasia.
    Grandin CB; Van Beers BE; Pauwels S; Demeure R; Jamart J; Pringot J
    J Magn Reson Imaging; 1997; 7(1):125-9. PubMed ID: 9039602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.